Table 2

Univariable analysis of factors associated with a Trichomonas vaginalis transcription-mediated amplification (TV TMA) test result

 Female
TV NAAT result
Fisher's exact test p valueMale
TV NAAT result
Fisher's exact test p value
Positive (N=72)Negative (N=62)Positive (N=21)Negative (N=38)
Age0.3270.439
 Not known0 (0.0%)0 (0.0%)0 (0.0%)0 (0.0%)
 <209 (40.9%)13 (59.1%)2 (33.3%)4 (66.7%)
 20–2419 (48.7%)20 (51.3%)5 (23.8%)16 (76.2%)
 25–2917 (65.4%)9 (34.6%)4 (36.4%)7 (63.6%)
 30+27 (57.4%)20 (42.6%)10 (47.6%)11 (52.4%)
Ethnicity0.001*<0.001*
 Not known0 (0.0%)0 (0.0%)0 (0.0%)1 (100.0%)
 White12 (30.0%)28 (70.0%)1 (5.6%)17 (94.4%)
 Black Caribbean40 (69.0%)18 (31.0%)16 (69.6%)7 (30.4%)
 Black African3 (50.0%)3 (50.0%)0 (0.0%)2 (100.0%)
 Asian2 (33.3%)4 (66.7%)2 (33.3%)4 (66.7%)
 Mixed/other†15 (62.5%)9 (37.5%)2 (22.2%)7 (77.8%)
Country of birth0.027*0.001*
 Not known0 (0.0%)0 (0.0%)0 (0.0%)0 (0.0%)
 UK54 (52.9%)48 (47.1%) 15 (34.9%)28 (65.1%)
 Europe‡1 (16.7%)5 (83.8%)0 (0.0%)4 (100.0%)
 Africa1 (20.0%)4 (80.0%) 0 (0.0%)3 (100.0%)
 Caribbean14 (73.7%)5 (26.3%)6 (100.0%)0 (0.0%)
 Asia Pacific2 (100.0%)0 (0.0%)0 (0.0%)3 (100.0%)
Sexual orientation0.4380.500
 Not known4 (30.8%)9 (69.2%)0 (0.0%)10 (100.0%)
 Heterosexual68 (56.7%)52 (43.3%) 21 (44.7%)26 (55.3%)
 Same sex partner0 (0.0%)0 (0.0%)0 (0.0%)2 (100.0%)
 Bisexual0 (0.0%)1 (100.0%)0 (0.0%)0 (0.0%)
Self-assessed symptoms0.2660.005*
 Not known0 (0.0%)0 (0.0%)0 (0.0%)0 (0.0%)
 Yes53 (57.5%)40 (43.0%) 10 (66.7%)5 (33.3%)
 No19 (46.3%)22 (53.7%)11 (25.0%)33 (75.0%)
Clinically identified signs0.1580.057
 Not known17 (42.5%)23 (57.5%)9 (28.1%)23 (71.9%)
 Yes44 (62.9%)26 (37.1%)7 (70.0%)3 (30.0%)
 No11 (45.8%)13 (54.2%)5 (29.4%)12 (70.6%)
Other sexual infection§0.2240.754
 Not known0 (0.0%)0 (0.0%)0 (0.0%)0 (0.0%)
 Yes28 (47.5%)31 (52.5%)4 (30.8%)9 (69.2%)
 No44 (58.7%)31 (41.3%)17 (37.0%)29 (63.0%)
Number of partners in the last 3 months0.3551.000
 Not known4 (36.4%)7 (63.6%)0 (0.0%)6 (100.0%)
 0 or 153 (53.0%)47 (47.0%) 13 (39.4%)20 (60.6%)
 More than 115 (65.2%)8 (34.8%)8 (40.0%)12 (60.0%)
  • *Significant at p<0.05.

  • †Mixed white/black Caribbean or white/black African or mixed white/Asian or Middle Eastern.

  • ‡Rest of Europe excluding UK.

  • §Chlamydia, gonorrhoea, HIV, syphilis, PID, warts, BV, NSU, Candida, HSV.

  • NAAT, nucleic acid amplification test; NSU, non-specific urethritis.